On October 27, 2019, Conquer Myasthenia Gravis hosted its Fall Patient Seminar. Speakers: Click to see these videos from the seminar. And keep reading below for seminar highlights. Clinical Trials: What MG patients need to know – Rabia Malik, MD Clinical Trials Q&A: What Patient, Doctor &… Read more »
As of January 2020, a number of clinical drug trials are recruiting participants. Details about these studies can be found at www.clinicaltrials.gov. Biotech companies also may have a webpage dedicated to the therapy they are studying. Sponsor: argenx BVBA. A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Trial to Evaluate the Efficacy, Safety and Tolerability of… Read more »
Will you keep this work going? A message from Bob Rosecrans, Conquer MG Chairperson Conquer MG is at a crossroads and the organization’s existence requires people to step up and volunteer to assist with numerous programs. The organization is supporting an NIH-funded grant called MGNet, working with its Chicago-based Medical Advisory Board, providing financial patient… Read more »
Bakers Square Sweet Returns™ cards – $18 each This season help those who struggle with myasthenia gravis – and enjoy mouthwatering holiday pies at the same time! When you purchase Bakers Square Sweet Returns™ cards for $18 apiece, a portion of your contribution goes toward Conquer MG’s effort to provide vital MG information to 2,000… Read more »
Conquer MG is excited to share news that the National Institutes of Health (NIH) has awarded a team at the George Washington University (GW) $7.8 million to establish a rare disease network for myasthenia gravis. Conquer MG will join scientists and physicians from academic institutions, other patient advocacy groups, and biotech/pharma companies, to better understand… Read more »
